ROMANO, GIOVANNI LUCA
 Distribuzione geografica
Continente #
NA - Nord America 1.738
AS - Asia 433
EU - Europa 422
SA - Sud America 179
AF - Africa 12
Totale 2.784
Nazione #
US - Stati Uniti d'America 1.721
IE - Irlanda 196
SG - Singapore 192
BR - Brasile 152
HK - Hong Kong 146
IT - Italia 79
FR - Francia 36
GB - Regno Unito 26
DE - Germania 25
VN - Vietnam 21
TR - Turchia 15
BD - Bangladesh 14
FI - Finlandia 13
AR - Argentina 11
IN - India 9
PL - Polonia 8
RU - Federazione Russa 7
CA - Canada 6
ES - Italia 6
UA - Ucraina 5
ZA - Sudafrica 5
JP - Giappone 4
PK - Pakistan 4
VE - Venezuela 4
CO - Colombia 3
IL - Israele 3
IQ - Iraq 3
KG - Kirghizistan 3
KR - Corea 3
LT - Lituania 3
PH - Filippine 3
BG - Bulgaria 2
CL - Cile 2
GR - Grecia 2
JM - Giamaica 2
KZ - Kazakistan 2
LV - Lettonia 2
MA - Marocco 2
MX - Messico 2
PE - Perù 2
PY - Paraguay 2
SE - Svezia 2
TN - Tunisia 2
UZ - Uzbekistan 2
AL - Albania 1
AT - Austria 1
BE - Belgio 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CN - Cina 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
GE - Georgia 1
HN - Honduras 1
ID - Indonesia 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
NI - Nicaragua 1
NL - Olanda 1
PA - Panama 1
PT - Portogallo 1
SA - Arabia Saudita 1
SC - Seychelles 1
SV - El Salvador 1
TH - Thailandia 1
TJ - Tagikistan 1
TM - Turkmenistan 1
UY - Uruguay 1
VC - Saint Vincent e Grenadine 1
Totale 2.784
Città #
Dallas 1.316
Dublin 195
Hong Kong 145
Boardman 85
Singapore 68
Santa Clara 57
Los Angeles 50
The Dalles 45
Ashburn 22
Catania 16
Milan 12
Palermo 12
Helsinki 11
Istanbul 11
São Paulo 11
Frankfurt am Main 10
London 10
Assago 8
West Jordan 8
Ho Chi Minh City 7
Munich 7
Rio de Janeiro 7
San Francisco 7
Brooklyn 6
Chicago 6
Düsseldorf 6
Columbus 5
New York 5
Belo Horizonte 4
Boston 4
Curitiba 4
Franca 4
Hanoi 4
Manchester 4
Montreal 4
Naples 4
St Petersburg 4
Tokyo 4
Wroclaw 4
Bishkek 3
Buenos Aires 3
Enna 3
Johannesburg 3
Lauterbourg 3
Manila 3
Mascalucia 3
Portsmouth 3
Raleigh 3
Rome 3
Roubaix 3
Salvador 3
Seoul 3
Warsaw 3
Almaty 2
Amparo 2
Athens 2
Barranquilla 2
Bexley 2
Caxias do Sul 2
Charlotte 2
Denver 2
Dhaka 2
Florence 2
Formello 2
Governador Valadares 2
Helena 2
Islamabad 2
Itaquaquecetuba 2
Jundiaí 2
Magé 2
Maricá 2
Mexico City 2
Moscow 2
New Delhi 2
Novara 2
Phoenix 2
Riga 2
Secaucus 2
Sofia 2
Stockholm 2
Sumaré 2
Tashkent 2
Tel Aviv 2
Turku 2
Abidjan 1
Aksaray 1
Alvorada 1
Arapiraca 1
Ashgabat 1
Asunción 1
Bady Bassitt 1
Bari 1
Barquisimeto 1
Barra de São Francisco 1
Barretos 1
Batumi 1
Beijing 1
Belém 1
Ben Arous 1
Bento Gonçalves 1
Totale 2.312
Nome #
Extramedullary Acute Myeloid Leukemia: Evaluating Azacitidine-Venetoclax Combination Outcomes and the Role of Molecular Genetics and Bone Marrow Involvement 314
Length of Washout Period After Remission Does Not Influence Relapse Risk in Patients with Acute Myeloid Leukemia Treated with Hypomethylating Agents Combined with Venetoclax 308
Does the Timing of Response Impact the Outcome of Relapsed/Refractory Acute Myeloid Leukemia Treated with Venetoclax in Combination with Hypomethylating Agents? A Proof of Concept from a Monocentric Observational Study 308
Diet and Nutrients in Rare Neurological Disorders: Biological, Biochemical, and Pathophysiological Evidence 77
Corneal wound healing and nerve regeneration by novel ophthalmic formulations based on cross-linked sodium hyaluronate, taurine, vitamin B6, and vitamin B12 61
Fluoxetine Protects Retinal Ischemic Damage in Mice 58
The Role of Pericytes in Inner Ear Disorders: A Comprehensive Review 58
Effects of Topical Fucosyl-Lactose, a Milk Oligosaccharide, on Dry Eye Model: An Example of Nutraceutical Candidate 57
Caffeine Protects Against Retinal Inflammation 54
Early Access for Medicines in ITALY: The Case of Ruxolitinib for Patients with Graft-Versus-Host Disease 53
COVID-19 surface persistence: A recent data summary and its importance for medical and dental settings 52
P2X7 receptor antagonism preserves retinal ganglion cells in glaucomatous mice 50
Anesthetic preconditioning as endogenous neuroprotection in glaucoma 47
New nanotechnology formulations for HuR siRNA delivery to the retina 46
Curcumin prevents high glucose damage in retinal pigment epithelial cells through ERK1/2-mediated activation of the Nrf2/HO-1 pathway 45
Epiretinal Membrane Vitrectomy With and Without Intraoperative Intravitreal Dexamethasone Implant: A Systematic Review With Meta-Analysis 45
Effects of novel hybrids of caffeic acid phenethyl ester and NSAIDs on experimental ocular inflammation 44
Efficacy and Safety of Subthreshold Micropulse Yellow Laser for Persistent Diabetic Macular Edema After Vitrectomy: A Pilot Study 43
The Role of Pericytes in Inner Ear Disorders: A Comprehensive Review 42
Retinal pharmacodynamic and pharmacokinetics profile of cannabidiol in an in vivo model of retinal excitotoxicity 41
Endosseous Dental Implant Materials and Clinical Outcomes of Different Alloys: A Systematic Review 41
Nicotinamide-rich diet in dba/2j mice preserves retinal ganglion cell metabolic function as assessed by perg adaptation to flicker 40
TGF-β1 prevents rat retinal insult induced by amyloid-β (1–42) oligomers 39
The Effects of Peripubertal THC Exposure in Neurodevelopmental Rat Models of Psychopathology 39
Drug-Repurposing Strategy for Dimethyl Fumarate 39
Nanotechnology approaches for intravitreal release of HuR siRNA 38
Editorial: Innovation in ocular pharmacology 37
Diabetes Exacerbates the Intraocular Pressure-Independent Retinal Ganglion Cells Degeneration in the DBA/2J Model of Glaucoma 37
MicroRNA target prediction in glaucoma 37
Resveratrol and vascular health: evidence from clinical studies and mechanisms of actions related to its metabolites produced by gut microbiota 35
Severe Gastrointestinal Toxicity Following the Use of Gilteritinib: A Case Series and Analysis of Postmarketing Surveillance Data 35
Topically administered NOX4 inhibitor, GLX7013114, is efficacious in treating the early pathological events of diabetic retinopathy 35
Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammation 35
Health Technology Assessment of Advanced Therapy Medicinal Products: Comparison Among 3 European Countries 35
Melatonin loaded hybrid nanomedicine: DoE approach, optimization and in vitro study on diabetic retinopathy model 34
Prognostic significance of deregulated microRNAs in uveal melanomas 33
INFECTIOUS ENDOCARDITIS IN DENTISTRY: A SUMMARY REVIEW ON RISKS AND THERAPIES 33
Periodontal Disease and Pregnancy: Correlation with Underweight Birth 32
Influence of different surfactants on the technological properties and in vivo ocular tolerability of lipid nanoparticles 32
Gels in medicine and surgery: Current trends and future perspectives 30
New Therapeutic Perspectives in the Treatment of Uveal Melanoma: A Systematic Review 30
The therapeutic value of treatment for multiple sclerosis: analysis of health technology assessments of three European countries 30
Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach 30
Brimonidine is Neuroprotective in Animal Paradigm of Retinal Ganglion Cell Damage 30
Lipid nanoparticles traverse non-corneal path to reach the posterior eye segment: In vivo evidence 30
Isoflavones Effects on Vascular and Endothelial Outcomes: How Is the Gut Microbiota Involved? 29
Access to Innovative Neurological Drugs in Europe: Alignment of Health Technology Assessments Among Three European Countries 29
Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery 28
Off-Label Use of Venetoclax in Patients With Acute Myeloid Leukemia: Single Center Experience and Data From Pharmacovigilance Database 28
Retinal and Circulating miRNAs in Age-Related Macular Degeneration: An In vivo Animal and Human Study 28
Retinal biomarkers and pharmacological targets for Hermansky-Pudlak syndrome 7 26
Influence of trace elements on neurodegenerative diseases of the eye—the glaucoma model 26
Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia: Are Supporting Evidences Enough? 25
Pegylated asparaginase-induced liver injury, a case-based review and data from pharmacovigilance 23
Retinal Protection of New Nutraceutical Formulation 13
Totale 2.924
Categoria #
all - tutte 14.038
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.038


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024302 0 0 0 0 0 0 0 0 66 65 105 66
2024/2025999 70 61 59 20 95 171 48 69 121 107 118 60
2025/20261.623 98 352 1.164 9 0 0 0 0 0 0 0 0
Totale 2.924